HCW BIOLOGICS INC.

(HCWB)
  Report
Delayed Nasdaq  -  03:42 2022-06-29 pm EDT
2.150 USD   +0.94%
06/17HCW BIOLOGICS INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/23HCW Biologics to Participate in H.C. Wainwright Annual Global Life Sciences Conference May 23 – 25, 2022
AQ
05/19HCW BIOLOGICS INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

HCW Biologics Inc.(NasdaqGM:HCWB) added to S&P TMI Index

09/20/2021 | 12:00am EDT

HCW Biologics Inc.(NasdaqGM:HCWB) added to S&P TMI Index


© S&P Capital IQ 2021
All news about HCW BIOLOGICS INC.
06/17HCW BIOLOGICS INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/23HCW Biologics to Participate in H.C. Wainwright Annual Global Life Sciences Conference ..
AQ
05/19HCW BIOLOGICS INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K..
AQ
05/13Earnings Flash (HCWB) HCW BIOLOGICS Reports Q1 Revenue $3.12M
MT
05/13HCW BIOLOGICS INC. Management's Discussion and Analysis of Financial Condition and Res..
AQ
05/13HCW Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/13HCW Biologics Reports First Quarter 2022 Financial Results and Recent Business Highligh..
GL
05/13HCW Biologics Reports First Quarter 2022 Financial Results and Recent Business Highligh..
AQ
05/05HCW Biologics to Showcase Two Novel Groups of Fusion Molecules Created with Proprietary..
GL
05/05HCW Biologics to Showcase Two Novel Groups of Fusion Molecules Created with Proprietary..
AQ
More news
Analyst Recommendations on HCW BIOLOGICS INC.
More recommendations
Financials (USD)
Sales 2022 3,11 M - -
Net income 2022 -17,8 M - -
Net Debt 2022 - - -
P/E ratio 2022 -4,34x
Yield 2022 -
Capitalization 77,0 M 77,0 M -
Capi. / Sales 2022 24,8x
Capi. / Sales 2023 -
Nbr of Employees 44
Free-Float 40,6%
Chart HCW BIOLOGICS INC.
Duration : Period :
HCW Biologics Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HCW BIOLOGICS INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 2,15 $
Average target price 7,00 $
Spread / Average Target 226%
EPS Revisions
Managers and Directors
Hing C. Wong Chief Executive Officer, Secretary & Director
Rebecca Byam Chief Financial Officer
Scott T. Garrett Chairman
Peter R. Rhode Chief Scientific Officer & VP-Clinical Operations
Rick Scott Greene Independent Director
Sector and Competitors
1st jan.Capi. (M$)
HCW BIOLOGICS INC.-8.19%76
GILEAD SCIENCES, INC.-14.32%78 031
VERTEX PHARMACEUTICALS25.76%70 632
REGENERON PHARMACEUTICALS, INC.-5.87%64 046
WUXI APPTEC CO., LTD.-14.46%44 352
BIONTECH SE-45.76%33 979